
TLR7/8 антагонист 1 (Compound 16c) is the мощный антагонист of TLR7/8 with IC50s of 3.91 and 2.19 μM, respectively. TLR7/8 антагонист 1 is an imidazoquinoline derivative compound. Toll-like receptors (TLRs) 7 and 8 are key targets in the development of immunomodulatory drugs for treating infectious disease, cancer, and autoimmune disorders.
TLR7/8 Antagonist 1 (Compound 16c) is the potent antagonist of TLR7/8 with IC50s of 3.91 and 2.19 μM, respectively. TLR7/8 Antagonist 1 is an imidazoquinoline derivative compound. Toll-like receptors (TLRs) 7 and 8 are key targets in the development of immunomodulatory drugs for treating infectious disease, cancer, and autoimmune disorders.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.